247 related articles for article (PubMed ID: 15152093)
21. Recombinant glutamate carboxypeptidase II (prostate specific membrane antigen--PSMA)--cellular localization and bioactivity analyses.
Meighan MA; Dickerson MT; Glinskii O; Glinsky VV; Wright GL; Deutscher SL
J Protein Chem; 2003 May; 22(4):317-26. PubMed ID: 13678295
[TBL] [Abstract][Full Text] [Related]
22. A novel PSMA/GCPII-deficient mouse model shows enlarged seminal vesicles upon aging.
Vorlová B; Sedlák F; Kašpárek P; Šrámková K; Malý M; Zámečník J; Šácha P; Konvalinka J
Prostate; 2019 Feb; 79(2):126-139. PubMed ID: 30256431
[TBL] [Abstract][Full Text] [Related]
23. Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition.
Sedlák F; Kvasnička A; Marešová B; Brumarová R; Dobešová D; Dostálová K; Šrámková K; Pehr M; Šácha P; Friedecký D; Konvalinka J
ACS Chem Neurosci; 2024 Apr; 15(7):1342-1355. PubMed ID: 38377674
[TBL] [Abstract][Full Text] [Related]
24. GCPII imaging and cancer.
Foss CA; Mease RC; Cho SY; Kim HJ; Pomper MG
Curr Med Chem; 2012; 19(9):1346-59. PubMed ID: 22304713
[TBL] [Abstract][Full Text] [Related]
25. Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery.
Tykvart J; Schimer J; Bařinková J; Pachl P; Poštová-Slavětínská L; Majer P; Konvalinka J; Šácha P
Bioorg Med Chem; 2014 Aug; 22(15):4099-108. PubMed ID: 24954515
[TBL] [Abstract][Full Text] [Related]
26. Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility.
Divyya S; Naushad SM; Addlagatta A; Murthy PV; Reddy ChR; Digumarti RR; Gottumukkala SR; Kumar A; Rammurti S; Kutala VK
Gene; 2012 Apr; 497(2):273-9. PubMed ID: 22310383
[TBL] [Abstract][Full Text] [Related]
27. Effect of carbohydrate moieties on the folate hydrolysis activity of the prostate specific membrane antigen.
Ghosh A; Heston WD
Prostate; 2003 Oct; 57(2):140-51. PubMed ID: 12949938
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of genetic variants of glutamate carboxypeptidase II in predicting breast cancer and prostate cancer risk.
Naushad SM; Shree Divyya P; Janaki Ramaiah M; Alex Stanley B; Prasanna Lakshmi S; Vishnupriya J; Kutala VK
Cancer Genet; 2015 Nov; 208(11):552-8. PubMed ID: 26471812
[TBL] [Abstract][Full Text] [Related]
29. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors.
Urazaev AK; Grossfeld RM; Lieberman EM
J Neurochem; 2005 May; 93(3):605-10. PubMed ID: 15836619
[TBL] [Abstract][Full Text] [Related]
30. Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk.
Divyya S; Naushad SM; Addlagatta A; Murthy PV; Reddy ChR; Digumarti RR; Gottumukkala SR; Subbarao SA; Kutala VK
Gene; 2013 Mar; 516(1):76-81. PubMed ID: 23266799
[TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of canine prostate-specific membrane antigen.
Schmidt S; Fracasso G; Colombatti M; Naim HY
Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
[TBL] [Abstract][Full Text] [Related]
32. Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA.
Mesters JR; Henning K; Hilgenfeld R
Acta Crystallogr D Biol Crystallogr; 2007 Apr; 63(Pt 4):508-13. PubMed ID: 17372356
[TBL] [Abstract][Full Text] [Related]
33. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate.
Bacich DJ; Ramadan E; O'Keefe DS; Bukhari N; Wegorzewska I; Ojeifo O; Olszewski R; Wrenn CC; Bzdega T; Wroblewska B; Heston WD; Neale JH
J Neurochem; 2002 Oct; 83(1):20-9. PubMed ID: 12358725
[TBL] [Abstract][Full Text] [Related]
34. The calcium-binding site of human glutamate carboxypeptidase II is critical for dimerization, thermal stability, and enzymatic activity.
Ptacek J; Nedvedova J; Navratil M; Havlinova B; Konvalinka J; Barinka C
Protein Sci; 2018 Sep; 27(9):1575-1584. PubMed ID: 30168215
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents.
Kozikowski AP; Zhang J; Nan F; Petukhov PA; Grajkowska E; Wroblewski JT; Yamamoto T; Bzdega T; Wroblewska B; Neale JH
J Med Chem; 2004 Mar; 47(7):1729-38. PubMed ID: 15027864
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide.
Conway RE; Rojas C; Alt J; Nováková Z; Richardson SM; Rodrick TC; Fuentes JL; Richardson NH; Attalla J; Stewart S; Fahmy B; Barinka C; Ghosh M; Shapiro LH; Slusher BS
Angiogenesis; 2016 Oct; 19(4):487-500. PubMed ID: 27387982
[TBL] [Abstract][Full Text] [Related]
37. Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay.
Rojas C; Frazier ST; Flanary J; Slusher BS
Anal Biochem; 2002 Nov; 310(1):50-4. PubMed ID: 12413472
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of 68Ga-Glutamate Carboxypeptidase II Ligand Positron Emission Tomography for Clinical Molecular Imaging of Atherosclerotic Plaque Neovascularization.
Derlin T; Thiele J; Weiberg D; Thackeray JT; Püschel K; Wester HJ; Aguirre Dávila L; Larena-Avellaneda A; Daum G; Bengel FM; Schumacher U
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2213-2219. PubMed ID: 27609368
[TBL] [Abstract][Full Text] [Related]
39. In silico approaches to identify the potential inhibitors of glutamate carboxypeptidase II (GCPII) for neuroprotection.
Naushad SM; Janaki Ramaiah M; Stanley BA; Prasanna Lakshmi S; Vishnu Priya J; Hussain T; Alrokayan SA; Kutala VK
J Theor Biol; 2016 Oct; 406():137-42. PubMed ID: 27430729
[TBL] [Abstract][Full Text] [Related]
40. Structural characterization of P1'-diversified urea-based inhibitors of glutamate carboxypeptidase II.
Pavlicek J; Ptacek J; Cerny J; Byun Y; Skultetyova L; Pomper MG; Lubkowski J; Barinka C
Bioorg Med Chem Lett; 2014 May; 24(10):2340-5. PubMed ID: 24731280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
